RI

Rayyan Ibrahim

Active Director Director DIN 02057736
DIN 02057736 First appointment Mar 2008 Primary industry Machinery and Equipment
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 9 active board seats
Past companies 8 historical roles
Total affiliations 17 Since Mar 2008
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 06 Mar 2008
Active appointments 12
Total timeline records 17

Rayyan Ibrahim (DIN 02057736) has 17 recorded board appointments in Indian companies, the first from March 2008, of which 12 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2008
Current
Atlantis Pharmacy Plus Private Limited Director · 2023 – present
Current
Vis Surgemed Private Limited Director · 2023 – present
Current
Grozpices Agro Products Private Limited Director · 2022 – present
Current
Rayan Healthcare Infra Private Limited Managing Director · 2021 – present
Current
Atlantis Healthcity Private Limited Director · 2021 – present
Current
Current
Colorbath Limited Liability Partnership Designated Partner · 2018 – present
Current
Qube Elevators Private Limited Director · 2016 – present
Current
Blufour Technologies Private Limited Director · 2013 – present
Current
Rayan Ibrahim Architects Private Limited Director · 2011 – present
Current
Rayan Properties Private Limited Director · 2010 – present
Current
Previous
Previous
Qun Constructions Private Limited Director · 2010 – 2013
Previous
Qun Interiors Private Limited Director · 2010 – 2011
Previous
True Pharma Private Limited Director · 2008 – 2010
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available